Subclinical hypothyroidism and anxiety may contribute to metabolic syndrome in Sichuan of China: a hospital-based population study

Li, Ruicen; Zhang, Lingyun; Luo, Han; Lei, Yali; Zeng, Li; Zhu, Jingqiang; Tang, Huairong

doi:10.1038/s41598-020-58973-w

Cited by 23 publications

(14 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, after controlling for age and marital status, we found that they were not independent risk factors for MetS in AMD patients. This is inconsistent with previous studies, including several that have found that anxiety is a risk factor for MetS 18 , 42 . Other studies have also found that depression and anxiety further increase the risk of T2DM and cardiovascular events 43 , 44 .…”

Section: Discussioncontrasting

confidence: 99%

“…Regarding psychotic symptoms, previous studies have demonstrated the potential interactions between psychotic symptoms and MetS 18 , 53 . Our study also found that compared with those with no psychiatric symptoms, AMD patients with psychiatric symptoms had a nearly twofold increased risk of MetS (OR 1.728, 95% CI 1.049–2.848), indicating that psychiatric symptoms may further increase the risk of MetS in AMD patients.…”

Section: Discussionmentioning

confidence: 99%

“…However, the results of studies on the association between anxiety and MetS are inconsistent. Some authors have reported that anxiety, rather than depression, is associated with MetS 18 , 19 . Anxiety severity has a greater impact on MetS than depression severity 20 .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety

Zhong

Wang

et al. 2021

Sci Rep

View full text Add to dashboard Cite

Metabolic syndrome (MetS) is associated with depression, but its role in major depressive disorder comorbid with anxiety (AMD) is unclear. This study aimed to investigate the prevalence and clinical correlates of MetS in first-episode drug-naive (FEDN) patients with AMD in a Chinese Han population. In total, 1380 FEDN outpatients with AMD were recruited in this cross-sectional study. The sociodemographic features, clinical characteristics, history of suicide attempts, thyroid-stimulating hormone (TSH) levels, and MetS parameters of each subject were evaluated. All subjects were rated on the Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A), and the Positive and Negative Syndrome Scale positive symptom subscale. The prevalence of MetS among AMD patients was 8.04%. Compared to the non-MetS group, age, age of onset, TSH level, HAM-A and HAM-D scores, history of attempted suicide, and comorbid psychiatric symptoms were higher in the MetS group. Those in this group were also more likely to be married, and they had a lower educational level. Furthermore, age, psychiatric symptoms, suicide attempts, and higher TSH levels were independently associated with MetS in AMD patients. This study suggests a lower prevalence of MetS in FEDN patients with AMD in a Chinese Han population. Older age, comorbid psychiatric symptoms, history of attempted suicide, and higher TSH levels are related factors for MetS in AMD patients.

show abstract

Section: Discussioncontrasting

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety

Zhong

Wang

et al. 2021

Sci Rep

View full text Add to dashboard Cite

show abstract

“…In a study of R. Li et al (2020), a multivariate analysis conducted among patients in China identified SH as an independent risk factor for the development of MS [18]. Interestingly, the multivariate logistic regression analysis performed by L. Jiang et al (2020), demonstrated the opposite impact, namely BMI and BP were independent predictors of SH development in women [19].…”

Section: Discussionmentioning

confidence: 99%

Prevalence of cardiometabolic risk factors in patients with hypertension and subclinical hypothyroidism

Radchenko

Kolesnikova

2021

ZMJ

View full text Add to dashboard Cite

It is known that the presence of overt hypothyroidism carries additional risks of developing cardiovascular diseases due to impaired lipid and carbohydrate metabolism. But whether subclinical hypothyroidism (SH) has the same negative impact is still controversial. The assessment of its role is especially important in patients with existing arterial hypertension (AH) in the early stages of the disease in order to prevent future complications. The aim of this work is to identify and assess the prevalence of early cardiometabolic risk factors in patients with AH combined with SH. Materials and methods. 66 patients (55.4 % women) aged from 25 to 59 years with a median age of 51.1 years were included in the study during 2019–2020 years. All the patients were divided into 3 groups, randomized by age and sex: group 1 (n = 21) – volunteers without AH and SH; group 2 (n = 25) – euthyroid patients with stage 1–2 grade 1–2 AH and low-to-moderate cardiovascular risk (CVR); group 3 (n = 20) – patients with stage 1–2 grade 1–2 AH and low-to-moderate CVR in combination with SH. Blood pressure was measured, anthropometric data were assessed, glucose levels and lipid profile indicators were determined in all patients. Results. Comparative characteristics of the groups showed a rise in the frequency of detecting increased waist circumference and the waist-to-hip ratio, obesity, metabolic syndrome, its individual components and lipid profile disorders, especially the levels of total cholesterol and high-density lipoprotein cholesterol in patients with SH even in the early stages of AH and CVR of low gradations. However, dyslipidemias in general and hypertriglyceridemia in particular were more common in euthyroid hypertensive patients compared to patients with AH and concomitant SH. There was also a tendency towards an increase in gynoid obesity and a worsening of the lipid and carbohydrate profile disorders in SH patients in comparison to euthyroid patients with AH, although the differences were not statistically significant. Conclusions. Evaluation of cardiometabolic risk factors revealed the increase in severity of female obesity and worsening of abnormalities in lipid and carbohydrate profiles with the SH development in patients even in the early stages of AH and low-CVR, that additionally increases the risk of cardiovascular complications.

show abstract

“…This is a population-based cross-sectional study among subjects undergoing routine health examinations at our hospital’s health management center from November 2018 to August 2019. The West China Hospital, a tertiary hospital with three subcenters in Sichuan, provides over 60,000 routine physical examinations annually ( 21 , 22 ). Participants were enrolled into the study if they fulfilled the following inclusion criteria: voluntarily go to the Health Management Center of West China Hospital of Sichuan University for health examination between November 2018 and August 2019; aged over 18 years; willing to sign an informed consent form.…”

Section: Methodsmentioning

confidence: 99%

Association between serum 25-hydroxyvitamin d and myeloperoxidase: A cross-sectional study of a general population in China

Zhou

Bao

et al. 2022

Front. Nutr.

View full text Add to dashboard Cite

BackgroundSeveral studies have found a strong association between cardiovascular diseases and myeloperoxidase (MPO) as a marker of oxidative stress. Although the anti-inflammatory effects of vitamin D in adults have been validated, evidence about the relationship between MPO and 25(OH)D is lacking. This study aimed to investigate the relationship between MPO and 25(OH)D in the general Chinese population.MethodsFrom November 2018 to August 2019, a total of 6414 subjects were enrolled in a tertiary referral hospital in China, which included 3,122 women and 3,292 men. The dependent and independent variables were MPO and 25(OH)D, respectively. The confounders included age, sex, body mass index, waist-hip ratio, smoking status, alcohol drinking status, calcium, and parathyroid hormone concentration.ResultsIn the fully adjusted model, we found that MPO decreased by 0.12 (95% CI −0.16, −0.08), ng/mL for each unit (1 nmol/L) increase in 25(OH)D. When 25(OH) D was divided into quartiles, compared with Q1 (< 41.4 nmol/L), the adjusted beta coefficients (β) of MPO in Q2–Q4 were −2.29 (95% CI, −4.31 to −0.27), −4.76 (95% CI, −6.83 to −2.69), and −6.07 (95% CI, −8.23 to −3.92), respectively (P for the trend < 0.0001). When 25(OH) D was divided according to clinical severity, compared with the severely deficient (< 30 nmol/L) s≥ 30, < 50 nmol/L) and sufficient groups (≥ 50 nmol/L) were −2.59 (95% CI, −5.87 to 0.69) and −5.87 (95% CI, −9.17 to −2.57), respectively (P for the trend < 0.0001).ConclusionAfter adjusting for age, sex, BMI, waist-hip ratio, smoking status, alcohol status, calcium, and PTH, circulating 25(OH)D was negatively associated with MPO.

show abstract

Subclinical hypothyroidism and anxiety may contribute to metabolic syndrome in Sichuan of China: a hospital-based population study

Cited by 23 publications

References 42 publications

The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety

The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety

Prevalence of cardiometabolic risk factors in patients with hypertension and subclinical hypothyroidism

Association between serum 25-hydroxyvitamin d and myeloperoxidase: A cross-sectional study of a general population in China

Contact Info

Product

Resources

About